Legal Opinion
In Re Lorazepam & Clorazepate Antitrust Litigation
Court of Appeals for the D.C. Circuit
Decided January 18, 2011No. 08-5044PublishedCited by 31 opinions
1Opinion of the Court
631 F.3d 537 (2011)
In re LORAZEPAM & CLORAZEPATE ANTITRUST LITIGATION.
Blue Cross & Blue Shield of Massachusetts, et al., Appellees
v.
Mylan Laboratories, Inc. and Mylan Pharmaceuticals, Inc., Appellants.
Nos. 08-5044, 08-5045.
United States Court of Appeals, District of Columbia Circuit.
Argued October 8, 2010.
Decided January 18, 2011.
Jonathan M. Jacobson argued the cause for appellants. With him on the briefs were Seth C. Silber, D. Bruce Hoffman, and Ryan A. Shores. Neil K. Gilman entered an appearance.
Martin R. Lueck argued the cause for appellees. With him on the brief were Sara A. Poulos,…
2Cases cited16 opinions
- Steel Co. v. Citizens for a Better EnvironmentSupreme Court of the United States · 1998
- Insurance Corp. of Ireland v. Compagnie Des Bauxites De GuineeSupreme Court of the United States · 1982
- Exxon Mobil Corp. v. Allapattah Services, Inc.Supreme Court of the United States · 2005
- Owen Equipment & Erection Co. v. KrogerSupreme Court of the United States · 1978
- Strawbridge v. CurtissSupreme Court of the United States · 1806
11 more not listed; retrieve them via the Exa API.
3Cited by31 opinions
- Pennsylvania Public School Employees' Retirement System v. Morgan Stanley & Co.Court of Appeals for the Second Circuit · 2014
- F5 Capital v. PappasCourt of Appeals for the Second Circuit · 2017
- Doe v. Exxon Mobil Corp.Court of Appeals for the D.C. Circuit · 2011
- John Doe I v. Exxon Mobil CorpDistrict Court, District of Columbia · 2014
- Wendy Wagner v. Federal Election CommissionCourt of Appeals for the D.C. Circuit · 2013
26 more not listed; retrieve them via the Exa API.